SONOWAND's business area today is the integration of high quality 3D ultrasound and neuronavigation through the product SonoWand. The goal of future development is to broaden the clinical application range of this technology within neurosurgery and expand the concept to other clinical segments, i.e. surgical guidance and intervention in urology, breast surgery, abdominal treatment, ENT etc.
SONOWAND can see great potential in collaboration with MI Lab, especially due to the pioneer activity capabilities of St. Olavs University Hospital as well as Sintef Helse. The goal of the research is to implement new ideas into products for sale in the international market.
Web link: www.sonowand.com
Contact: Atle Kleven,
Director of Research & Special Operations
Tlf: 73 55 10 63